Progesterone Antagonists Increase Androgen Receptor Expression in the Rhesus Macaque and Human Endometrium1
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Antiprogestins (APs) inhibit estradiol (E(2))-stimulated endometrial growth in women and nonhuman primates, but the mechanism of this "antiestrogenic" action is unknown. Here, we report that APs up-regulate endometrial androgen receptor (AR) in both women and macaques, an effect that might play a role in the antiproliferative effects of APs on the primate endometrium. In addition, because there are discrepancies in the literature on the regulation and localization of AR in the primate endometrium, we used both in situ hybridization and immunocytochemistry to evaluate hormonal influences on endometrial AR in women and macaques. In ovariectomized macaques, the following treatments were given for 4 weeks each: E(2) alone, E(2) + progesterone (P), E(2) + mifepristone (RU 486), and E(2) + P + RU 486. In women, samples were obtained during the normal menstrual cycle and after treatment with either RU 486 for 30 days at 2 mg/day, or after a single oral administration of 200 mg RU 486 on cycle day LH + 2. In macaques, E(2) significantly increased AR expression above vehicle controls; E(2) + RU 486 increased binding further; E(2) + P decreased AR binding; and E(2) + P + RU 486 treatment caused an intermediate elevation in AR binding. In macaques treated with E(2) alone, stromal AR staining was predominant, and P treatment suppressed that staining. E(2) + RU 486 or E(2) + P + RU 486 treatment produced a striking up-regulation of glandular epithelial AR staining and enhanced the stromal AR signal. In situ hybridization analyses confirmed the immunocytochemistry data. Similar induction of glandular AR staining and enhanced stromal AR staining were obtained in macaques treated with ZK 137 316 and ZK 230 211. During the natural cycle in women, stromal AR staining predominated and was greater in the proliferative than the late secretory phase. RU 486 treatment of women up-regulated glandular epithelial AR staining after either daily treatment for 30 days with 2 mg/day or after a single oral dose of 200 mg. In summary, endometrial AR was highest in the stroma during the human proliferative phase (or during E(2) treatment in macaques) and lowest during the late secretory phase in women (or after E(2) + P treatment in macaques). In both species, RU 486 induced AR expression in the glands and enhanced AR expression in stromal cells. Because androgens can antagonize E(2) action, enhanced endometrial AR expression induced by APs could play a role in the antiproliferative, "antiestrogenic" effects of APs in primates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burton, K. (1956) · Biochemical Journal · doi:10.1042/bj0620315 · Cited by 14,090
Self-citationDo androgens have a direct effect on endometrial function? An in vitro study
Tuckerman, E. M., Okon, M. A., Li, T.-C., & Laird, S. M. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00711-1 · Cited by 167
Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion
Bussen, S. (1999) · Human Reproduction · doi:10.1093/humrep/14.1.18 · Cited by 121
Cited by
Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure
Gellersen, B., & Brosens, J. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1045 · Cited by 1,139
Endocrine regulation of menstruation
Jabbour, H. N., Kelly, R. W., Fraser, H. M., & Critchley, H. O. D. (2006) · Endocrine Reviews · doi:10.1210/er.2004-0021 · Cited by 588
Self-citationEndometrial function in women with polycystic ovary syndrome: a comprehensive review
Palomba, S., Piltonen, T. T., & Giudice, L. C. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmaa051 · Cited by 372
Endometrium in PCOS: Implantation and predisposition to endocrine CA
Giudice, L. C. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.03.005 · Cited by 328
Models for Study of Human Embryo Implantation: Choice of Cell Lines?1
Hannan, N. J., Paiva, P., Dimitriadis, E., & Salamonsen, L. A. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.109.077800 · Cited by 308
Elevated Endometrial Androgen Receptor Expression in Women with Polycystic Ovarian Syndrome1
Apparao, K. B. C., Lovely, L. P., Gui, Y., Lininger, R. A., & Lessey, B. A. (2002) · Biology of Reproduction · doi:10.1095/biolreprod66.2.297 · Cited by 265
Androgens in pregnancy: roles in parturition
Makieva, S., Saunders, P. T. K., & Norman, J. E. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu008 · Cited by 232
“…SHBG, which binds and inactivates elevated androgens (Hammond, 2011) (ii) the pregnancy-induced rapid elevation of P4, which competes for AR binding (Slayden et al., 2001; Birrell et al., 2007) and (iii) P4 having an affinity for 5a-reductase resulting in an inhibition of the conversion of T to…”
BackgroundThe endocrinology of menstruation – a role for the immune system
Critchley, H. O. D., Kelly, R. W., Brenner, R. M., & Baird, D. T. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01432.x · Cited by 203
“…receptor, ER; androgen receptor, AR), all of which are nuclear proteins, varies both temporally and spatially across the menstrual cycle (Garcia et al., 1988; Lessey et al., 1988; Snijders et al., 1992; Critchley & Healy, 1998; Burton et al. 2000; Critchley et al. 2001; Slayden et al. 2001).”
BackgroundSelf-citationCloke, B., Huhtinen, K., Fusi, L., Kajihara, T., Yliheikkilä, M., Ho, K.-K., Teklenburg, G., Lavery, S., Jones, M. C., Trew, G., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0356 · Cited by 159
Hormone receptor dynamics in a receptive human endometrium
Critchley, H. O. D., & Saunders, P. T. K. (2009) · Reproductive Sciences · doi:10.1177/1933719108331121 · Cited by 133
Self-citationAndrogens and endometrium: new insights and new targets
Simitsidellis, I., Saunders, P. T. K., & Gibson, D. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.022 · Cited by 107
Critchley, H. O. D., Henderson, T. A., Kelly, R. W., Scobie, G. S., Evans, L. R., Groome, N. P., & Saunders, P. T. K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020502 · Cited by 87
Self-citationRegulation of human endometrial function: mechanisms relevant to uterine bleeding
Critchley, H. O., Kelly, R. W., Baird, D. T., & Brenner, R. M. (2006) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-4-s1-s5 · Cited by 78
Self-citationThe role of androgens and the androgen receptor in cycling endometrium
Cloke, B., & Christian, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.031 · Cited by 77
Whitaker, L. H. R., Murray, A. A., Matthews, R., Shaw, G., Williams, A. R. W., Saunders, P. T. K., & Critchley, H. O. D. (2017) · Human Reproduction · doi:10.1093/humrep/dew359 · Cited by 77
“A similar effect has been reported following treatment with mifepristone, which increased stromal and glandular AR immunoexpression in Rhesus macaques (Slayden et al., 2001) and in women treated with a single postovulatory dose of the SPRM (Slayden et al.”
InfluentialSelf-citationRegulation of androgen action during establishment of pregnancy
Gibson, D. A., Simitsidellis, I., & Saunders, P. T. K. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0027 · Cited by 42
Forbes-Lorman, R., Auger, A. P., & Auger, C. J. (2014) · Brain Research · doi:10.1016/j.brainres.2013.11.012 · Cited by 12
Metadata
- Authors
- Slayden, O. D., Nayak, N. R., Burton, K. A., Chwalisz, K., Cameron, S. T., Critchley, H. O. D., Baird, D. T., & Brenner, R. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-06-01
- Volume
- 86
- Issue
- 6
- Pages
- 2668-2679
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2095904930
- Cited by
- 138
- References
- 3
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.